| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |